The Efficacy of Synchronous Combination of Chemotherapy and EGFR TKIs for the First-Line Treatment of NSCLC: A Systematic Analysis

BACKGROUND: The combination of chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) currently has become the hotspot issue in the treatment of non-small lung cancer (NSCLC). This systematic review was conducted to compare the efficacy and safety of the synchrono...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Han, Li, Huihui, Li, Qin, Zhao, Pengfei, Wang, Wei, Cao, Bangwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540576/
https://www.ncbi.nlm.nih.gov/pubmed/26285137
http://dx.doi.org/10.1371/journal.pone.0135829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540576/
https://www.ncbi.nlm.nih.gov/pubmed/26285137
http://dx.doi.org/10.1371/journal.pone.0135829

Ejemplares similares